Scientific Advisory Board
Amir Lahav, ScD, is a strategic consultant and a leading innovator in digital health with a special focus on validating novel biomarkers and AI-driven technology for remote monitoring of patients with neurodegenerative diseases. Amir has 15+ years of experience in the healthcare industry, academic research, clinical neuroscience, wearable intelligence, and digital data analytics.
He is currently the Head of R&D at Mitsubishi Tanabe Pharma Holding America, and a strategic consultant for several HealthTech companies in the DTx space developing mobile health apps and "Around the pill" solutions. Formerly, Amir served as the Head of Digital Innovation at Pfizer’s Rare Disease Research Unit, and was a PI on multiple technology-driven clinical trials as Harvard professor of pediatrics.
Amir Lahav, ScD
Head of R&D at Mitsubishi Tanabe Pharma Holding, America